Citation Classics in Lipid Measurement and Applications
In 1998 the AACC celebrates its 50th anniversary. Thus, we are honored to call attention to the outstanding professional contributions of the journal Clinical Chemistry over the years by pointing out the citation classics that have been published in its pages. By the end of 1995, 31 articles in Clinical Chemistry had been cited more than 300 times (1) . Thirty of these articles were still being cited in 1995, and some are still cited to the present day. These 31 papers are distributed in multiple areas of biological sciences, and in particular: lipids, 8 papers (2-9); endocrinology, 2 papers; clinical enzymology, 4 papers; intermediary metabolism, 6 papers; renal function, 2 papers; cancer, 1 paper; and calcium metabolism, 3 papers. Publications on methodology research and laboratory applications of lipid, lipoprotein, and apolipoprotein measurements in clinical investigations and epidemiologic trials have had a major impact on research of lipid metabolism and cardiovascular medicine (2) (3) (4) (5) (6) (7) (8) (9) . The combined efforts of epidemiologists, clinicians, and laboratorians have produced classic publications on the understanding of lipid metabolic disorders, have stimulated development of new novel equipment and methodology, and have helped to establish the development of beneficial preventive and control measures for diseases of the heart and blood vessels.
The cited lipid papers published in Clinical Chemistry included mainly the original papers on measurement of lipoproteins, enzymatic measurements of cholesterol and triglycerides, and immunoassays of apolipoproteins. The method used most widely today for estimation of the concentration of LDL-cholesterol (LDL-C) in both clinical and research laboratories arose from the publication of Friedewald et al. (2) that showed that the serum concentration of LDL-C can be estimated from available established measurements of total cholesterol (TC), HDL-cholesterol (HDL-C), and triglyceride (TG) in serum (Fig. 1.) . Prior to this, only time-consuming and expensive ultracentrifugal measurements were used to determine LDL-C in serum. The ability to calculate LDL-C thus permitted greater worldwide access to LDL-C estimates and allowed for the greater application of the more sensitive and specific LDL-C estimates in lieu of, or in conjunction with, TC in the assessment of coronary heart disease risk. The Friedewald equation has since been used as the basis of LDL-C estimation in several landmark trials of the clinical benefits of lipid modification, thus demonstrating its important role in the epidemiology of coronary heart disease.
HDL-C has become recognized as an important independent risk factor for coronary heart disease. Around 1960, colorimetric TG measurements were of questionable accuracy and lacked desired precision. Van Handel (8) optimized the colorimetric zeolite extraction, alcoholic KOH saponification, periodate, and chromotropic acid reagent method. He purified corn, cotton, and olive oil by shaking with ground zeolite after dissolving the oil in chloroform for use as a primary standard. A modification of this colorimetric method is the TG reference method for the Centers for Disease Control and Prevention.
A major breakthrough in cholesterol analysis resulted from development of enzymatic reagents for analytical measurements of TC. Richmond (7) isolated a cholesterol oxidase enzyme from a species of Nocardia, using a surfactant for solubilizing and ion-exchange chromatography for purifying the cholesterol-oxidizing enzyme. He determined the stability, substrate specificity, and optimal conditions under which the enzymatic oxidation reaction could occur and later combined alkaline ethanolic hydrolysis, enzymatic oxidation, and colorimetric estimation for automation of the total cholesterol analysis. Allain et al. (3) developed an automated method for total serum cholesterol using three enzymes (Fig. 3) : cholesteryl ester hydrolase was used for hydrolysis of cholesteryl esters, cholesterol oxidase for oxidation of cholesterol to form hydrogen peroxide, and peroxidase for oxidative coupling to develop color with 4-aminoantipyrine and phenol. Allain et al. (3) also developed assays for standardization of the enzymes for optimization experiments. These enzymatic cholesterol measurements are applicable to measurements of low cholesterol concentrations of HDL-C in serum.
Bucolo and David (4) improved the TG ultraviolet test by using a lipase together with a protease to replace chemical hydrolysis for formation of glycerol from the TG (Fig. 4) . The determination of glycerol by the enzymatic method with three coupling enzymes, glycerol kinase, pyruvate kinase, and lactic dehydrogenase, measured the decrease in the absorbance of NADH at 340 nm. This procedure became the most popular ultraviolet technique for measurement of the glycerol freed from TG because it could be used with most manual and automated laboratory instruments.
The development of immunochemical procedures permitted laboratory measurements of apolipoprotein (apo).
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In the cited article by Curry et al. (9) , electroimmunoassay was applied to the measurement of apo A without requiring the use of a radioisotope in the assay. apo A and its components apos A-I and A-II are quantified by electrophoresis of the antigen into agarose containing its corresponding antibody, a process that yields precipitates that resemble ascending rockets. Washed antigen-antibody precipitates are stained with lipid stains. This electroimmunoassay along with developed immunonephelometric assays became widely used across the United States to describe complexes, associations, and reference values for different apos.
Outstanding scientific articles continue to be published in and cited from Clinical Chemistry. The Institute for Scientific Information reported that in 1996, Clinical Chemistry was cited 14 144 times, mostly in general medical and specialty journals, and had an impact factor of 3.422, which was double that of the nearest journal in the same category. Lipid articles cited widely by investigators in the cardiovascular lipid discipline recognize the following (21) ; and (h) identifying and documenting new risk factors beyond those associated with lipid concentrations (22) .
In the future, Clinical Chemistry will be an excellent journal in which to explore important new coronary risk factors, such as homocysteine and lipoprotein remnants. The precise mechanisms whereby lipid-lowering drugs exert their antiatherogenic effects in the arteries, particularly how statins help prevent heart attacks and stroke, will also need to be addressed. Quantitative measurements of oxidized lipids and lipoproteins may help elucidate the relationship between these particles and endothelial dysfunction, inflammation, and atherosclerosis. Laboratory measurements of lipid risk factors will be aided by mass spectrometric methods to provide improved reference materials. Homogeneous methods will keep improving automated methods for lipid measurements for clinical and epidemiologic investigations. Inflammation and infectious disease sources of coronary disease risk will be detected and documented. Research on gene therapy also shows promise of producing exciting ways to reverse atherosclerosis. For example, in the laboratory of Weill Medical College of Cornell University, gene therapy has been used to induce new blood vessel formation in a pig model of total arterial occlusion, thus restoring impaired blood flow completely.
Without doubt, Clinical Chemistry will continue to be a highly desirable forum for publications by laboratories, clinicians, and epidemiologists of the scientific results of methodology research and collaborative laboratory, clinical, and epidemiologic studies. Although the achievements of the Journal have been excellent, we predict that its future contributions and continued commitment to the field of lipid and atherosclerosis research will be even more impressive.
